scholarly article | Q13442814 |
P50 | author | Hans-Georg Kräusslich | Q1576991 |
Hans Robert Kalbitzer | Q19284863 | ||
Jan Konvalinka | Q28360189 | ||
P2093 | author name string | R Kellner | |
J Freund | |||
V Wolber | |||
P2860 | cites work | Serine phosphorylation-independent downregulation of cell-surface CD4 by nef | Q22251290 |
Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 | ||
Specificity mapping of HIV-1 protease by reduced bond inhibitors. | Q39407416 | ||
Effect of myristoylation on p27nef subcellular distribution and suppression of HIV-LTR transcription | Q41635961 | ||
Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus | Q42071857 | ||
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product | Q59048755 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 589-593 | |
P577 | publication date | 1994-07-01 | |
P1433 | published in | FEBS Journal | Q1388041 |
P1476 | title | A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease | |
P478 | volume | 223 |
Q41718191 | AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles. |
Q41813849 | Alkylating HIV-1 Nef - a potential way of HIV intervention |
Q36874356 | Bioinformatic approaches for modeling the substrate specificity of HIV-1 protease: an overview |
Q39684211 | Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro |
Q41989123 | Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein |
Q45784368 | Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease |
Q40261243 | Comparative genetic variability in HIV-1 subtype C nef gene in early age groups of infants |
Q39736736 | Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex |
Q58136237 | Evidence for the association of Nef protein with HIV-2 virions |
Q28538038 | HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particles |
Q34050688 | HIV-1 protease: maturation, enzyme specificity, and drug resistance. |
Q33866230 | Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions |
Q42125314 | Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity |
Q39601382 | Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir |
Q39443718 | In-silico designing of a potent analogue against HIV-1 Nef protein and protease by predicting its interaction network with host cell proteins |
Q39875739 | Influence of extended mutations of the HIV-1 transframe protein p6 on Nef-dependent viral replication and infectivity in vitro |
Q34185928 | Nef alleles from all major HIV-1 clades activate Src-family kinases and enhance HIV-1 replication in an inhibitor-sensitive manner |
Q41142054 | Nef and the Nef-associated kinase |
Q36315000 | Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation |
Q34010283 | Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis |
Q35863401 | Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein |
Q35601697 | Proteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variants |
Q33180343 | Recombinant nef HIV-IIIB protein is toxic to human neurons in culture |
Q30176531 | Refined solution structure and backbone dynamics of HIV-1 Nef. |
Q42223515 | Sequence heterogeneity in human immunodeficiency virus type 1 nef in patients presenting with rapid progression and delayed progression to AIDS. |
Q39877488 | Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases |
Q24522550 | Structure--function relationships in HIV-1 Nef. |
Q30160188 | The HIV-1 Nef protein as a target for antiretroviral therapy |
Q24322710 | The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling |
Q41338314 | The positive influence of Nef on viral infectivity |
Q33783315 | The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity. |
Q28647550 | The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase |
Q33785282 | Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. |
Search more.